SCHEMBL19660464

SCHEMBL19660464

COc1ccc(-c2nc3cccc(I)c3o2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 8/20 0.58
RAB9A P51151 8/20 0.58
ALDH1A1 P00352 8/20 0.58
KDM4E B2RXH2 5/20 0.58
MAPT P10636 5/20 0.58
SMN1; SMN2 Q16637 4/20 0.58
LMNA P02545 2/20 0.58
APP P05067 1/20 0.49
HTR3A P46098 1/20 0.45
HPGD P15428 4/20 0.45
KMT2A Q03164 2/20 0.45
F2 P00734 1/20 0.45
PTPN2 P17706 1/20 0.44
PTPN1 P18031 1/20 0.44
PTPN5 P54829 1/20 0.44
DHODH Q02127 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
C1R P00736 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14266179 0.84 ALDH1A1 (0.59) NPC1RAB9AALDH1A1KDM4EMAPT
SCHEMBL5421354 0.82 APP (0.49) NPC1RAB9AALDH1A1KDM4EMAPT
SCHEMBL21237208 0.80 ALDH1A1 (0.56) NPC1RAB9AALDH1A1KDM4EMAPT
SCHEMBL28357340 0.79 ALDH1A1 (0.58) NPC1RAB9AALDH1A1KDM4EMAPT
SCHEMBL2950955 0.79 DHODH (0.72) NPC1RAB9AALDH1A1KDM4EMAPT
SCHEMBL2959887 0.77 HTR3A (0.58) NPC1RAB9AALDH1A1KDM4EMAPT
SCHEMBL29728167 0.77 KDM4E (0.62) NPC1RAB9AALDH1A1KDM4EMAPT
SCHEMBL20361419 0.76 ALDH1A1 (0.61) NPC1RAB9AALDH1A1KDM4EMAPT
SCHEMBL1199992 0.75 PTPN2 (0.68) NPC1RAB9AALDH1A1KDM4EMAPT
SCHEMBL29633759 0.73 ALDH1A1 (1.00) NPC1RAB9AALDH1A1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3464286-B1 PYRAZOLOPYRIDINE DERIVATIVES FOR THE TREATMENT OF CANCER GENENTECH INC (US) 2021-08-18 EP disclosed
WO-2017205538-A1 PYRAZOLOPYRIDINE DERIVATIVES FOR THE TREATMENT OF CANCER GENENTECH, INC. (US) 2017-11-30 WO disclosed